THE DUBERSTEIN GROUP INC. for PHRMA INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Health Care Reform: H.R.1628 - Better Care Reconciliation Act of 2017. Health Care Reform: H.R. 1628 (Black) - American Health Care Act Drug Re-importation: S.469 (Sanders) - Affordable and Safe Prescription Drug Importation Act. Prescription Drug User Fee Act (PDUFA).
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN GRIFFIN | — |
| DANIEL P MEYER | — |
| DAVID J SCHIAPPA | — |
| ANNE WALL | — |
Medicare/Medicaid MMM
IPAB Disapproval Resolution: -S.260 (Cornyn) - Protecting Seniors' Access to Medicare Act of 2017. -HJ Res. 51 (Roe/Ruiz) - Approving the discontinuation of the process for consideration and automatic implementation of the annual proposal of the Independent Medicare Advisory Board under section 1899A of the Social Security Act. -H.R.849 (Roe) - Protecting Seniors' Access to Medicare Act of 2017
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE ELLIOTT BRADBURY New | Small Business Admin (8/03-5/04) Rep Charles Boustany (2/05-8/05) Dep Floor Dir, Ofc of Maj Leader (Delay/Boehner) (8/05-12/05) Dep Floor Dir, Min Leader Boehner (1/06-12/10) Floor Dir, Spkr Boehner (1/11-10/15), Spkr Ryan (10/15-10/16) |
| DANIEL P MEYER | — |
| DAVID J SCHIAPPA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.